Cargando…
Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
SIMPLE SUMMARY: Early prediction of response to cancer therapies is critical for treatment personalisation. In patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiation therapy (nCRT), delta radiomics applied to mesorectal features could potentially lead to the develo...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296157/ https://www.ncbi.nlm.nih.gov/pubmed/37370692 http://dx.doi.org/10.3390/cancers15123082 |
_version_ | 1785063591471218688 |
---|---|
author | Chiloiro, Giuditta Cusumano, Davide Romano, Angela Boldrini, Luca Nicolì, Giuseppe Votta, Claudio Tran, Huong Elena Barbaro, Brunella Carano, Davide Valentini, Vincenzo Gambacorta, Maria Antonietta |
author_facet | Chiloiro, Giuditta Cusumano, Davide Romano, Angela Boldrini, Luca Nicolì, Giuseppe Votta, Claudio Tran, Huong Elena Barbaro, Brunella Carano, Davide Valentini, Vincenzo Gambacorta, Maria Antonietta |
author_sort | Chiloiro, Giuditta |
collection | PubMed |
description | SIMPLE SUMMARY: Early prediction of response to cancer therapies is critical for treatment personalisation. In patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiation therapy (nCRT), delta radiomics applied to mesorectal features could potentially lead to the development of predictive models of treatment response. Pre- and post-treatment MRIs of patients treated at a single institution were analysed. Radiomic features of the mesorectum and GTV were extracted and predictive models of pathological complete response (pCR) and two-year disease-free survival (2yDFS) were developed. In 203 patients with LARC, a total of 565 variables were evaluated; the best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. The mesorectum may contain important radiomics information for predicting response to nCRT treatment in LARC patients. ABSTRACT: Background: The aim of this study is to evaluate the delta radiomics approach based on mesorectal radiomic features to develop a model for predicting pathological complete response (pCR) and 2-year disease-free survival (2yDFS) in locally advanced rectal cancer (LARC) patients undergoing neoadjuvant chemoradiotherapy (nCRT). Methods: Pre- and post-nCRT MRIs of LARC patients treated at a single institution from May 2008 to November 2016 were retrospectively collected. Radiomic features were extracted from the GTV and mesorectum. The Wilcoxon–Mann–Whitney test and area under the receiver operating characteristic curve (AUC) were used to evaluate the performance of the features in predicting pCR and 2yDFS. Results: Out of 203 LARC patients, a total of 565 variables were evaluated. The best performing pCR prediction model was based on two GTV features with an AUC of 0.80 in the training set and 0.69 in the validation set. The best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. Conclusions: The results of this study suggest a possible role for delta radiomics based on mesorectal features in the prediction of 2yDFS in patients with LARC. |
format | Online Article Text |
id | pubmed-10296157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102961572023-06-28 Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer Chiloiro, Giuditta Cusumano, Davide Romano, Angela Boldrini, Luca Nicolì, Giuseppe Votta, Claudio Tran, Huong Elena Barbaro, Brunella Carano, Davide Valentini, Vincenzo Gambacorta, Maria Antonietta Cancers (Basel) Article SIMPLE SUMMARY: Early prediction of response to cancer therapies is critical for treatment personalisation. In patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiation therapy (nCRT), delta radiomics applied to mesorectal features could potentially lead to the development of predictive models of treatment response. Pre- and post-treatment MRIs of patients treated at a single institution were analysed. Radiomic features of the mesorectum and GTV were extracted and predictive models of pathological complete response (pCR) and two-year disease-free survival (2yDFS) were developed. In 203 patients with LARC, a total of 565 variables were evaluated; the best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. The mesorectum may contain important radiomics information for predicting response to nCRT treatment in LARC patients. ABSTRACT: Background: The aim of this study is to evaluate the delta radiomics approach based on mesorectal radiomic features to develop a model for predicting pathological complete response (pCR) and 2-year disease-free survival (2yDFS) in locally advanced rectal cancer (LARC) patients undergoing neoadjuvant chemoradiotherapy (nCRT). Methods: Pre- and post-nCRT MRIs of LARC patients treated at a single institution from May 2008 to November 2016 were retrospectively collected. Radiomic features were extracted from the GTV and mesorectum. The Wilcoxon–Mann–Whitney test and area under the receiver operating characteristic curve (AUC) were used to evaluate the performance of the features in predicting pCR and 2yDFS. Results: Out of 203 LARC patients, a total of 565 variables were evaluated. The best performing pCR prediction model was based on two GTV features with an AUC of 0.80 in the training set and 0.69 in the validation set. The best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. Conclusions: The results of this study suggest a possible role for delta radiomics based on mesorectal features in the prediction of 2yDFS in patients with LARC. MDPI 2023-06-07 /pmc/articles/PMC10296157/ /pubmed/37370692 http://dx.doi.org/10.3390/cancers15123082 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chiloiro, Giuditta Cusumano, Davide Romano, Angela Boldrini, Luca Nicolì, Giuseppe Votta, Claudio Tran, Huong Elena Barbaro, Brunella Carano, Davide Valentini, Vincenzo Gambacorta, Maria Antonietta Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer |
title | Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer |
title_full | Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer |
title_fullStr | Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer |
title_full_unstemmed | Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer |
title_short | Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer |
title_sort | delta radiomic analysis of mesorectum to predict treatment response and prognosis in locally advanced rectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296157/ https://www.ncbi.nlm.nih.gov/pubmed/37370692 http://dx.doi.org/10.3390/cancers15123082 |
work_keys_str_mv | AT chiloirogiuditta deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT cusumanodavide deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT romanoangela deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT boldriniluca deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT nicoligiuseppe deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT vottaclaudio deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT tranhuongelena deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT barbarobrunella deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT caranodavide deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT valentinivincenzo deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer AT gambacortamariaantonietta deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer |